Moisoiu, T.; Iancu, S.D.; Burghelea, D.; Dragomir, M.P.; Iacob, G.; Stefancu, A.; Cozan, R.G.; Antal, O.; Bálint, Z.; Muntean, V.;
et al. SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer. Biomedicines 2022, 10, 233.
https://doi.org/10.3390/biomedicines10020233
AMA Style
Moisoiu T, Iancu SD, Burghelea D, Dragomir MP, Iacob G, Stefancu A, Cozan RG, Antal O, Bálint Z, Muntean V,
et al. SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer. Biomedicines. 2022; 10(2):233.
https://doi.org/10.3390/biomedicines10020233
Chicago/Turabian Style
Moisoiu, Tudor, Stefania D. Iancu, Dan Burghelea, Mihnea P. Dragomir, Gheorghita Iacob, Andrei Stefancu, Ramona G. Cozan, Oana Antal, Zoltán Bálint, Valentin Muntean,
and et al. 2022. "SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer" Biomedicines 10, no. 2: 233.
https://doi.org/10.3390/biomedicines10020233
APA Style
Moisoiu, T., Iancu, S. D., Burghelea, D., Dragomir, M. P., Iacob, G., Stefancu, A., Cozan, R. G., Antal, O., Bálint, Z., Muntean, V., Badea, R. I., Licarete, E., Leopold, N., & Elec, F. I.
(2022). SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer. Biomedicines, 10(2), 233.
https://doi.org/10.3390/biomedicines10020233